J-J Chen
Overview
Explore the profile of J-J Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Expression of SATB1 is a prognostic indicator for survival in diffuse large B-cell lymphoma patients
Yi H, Wei Y, Chen J
Eur Rev Med Pharmacol Sci
. 2022 Feb;
26(2):382-390.
PMID: 35113413
Objective: Special AT-rich Sequence-binding Protein-1 (SATB1) and Matrix Attachment Region-binding Protein were associated with high tumor stage, tumor recurrence, tumor-related death and indicating a poor prognosis. The association between SATB1...
2.
Tseng P, Chen T, Sun Y, Chen Y, Chen J
QJM
. 2021 Jul;
114(9):663-664.
PMID: 34297133
No abstract available.
3.
Hsu K, Chien K, Tsai S, Tsai Y, Liao Y, Chen J, et al.
J Nutr Health Aging
. 2021 Jun;
25(6):727-734.
PMID: 34179925
Background: Obesity accelerates and exacerbates the age-related changes on muscle function and exercise capacity. In addition, the middle-aged population is often overlooked when talking about the prevention of sarcopenia. This...
4.
Liu Y, Trnka M, Guan S, Kwon D, Kim D, Chen J, et al.
Mol Cell Proteomics
. 2020 Sep;
19(12):1968-1986.
PMID: 32912968
Mallory-Denk-bodies (MDBs) are hepatic protein aggregates associated with inflammation both clinically and in MDB-inducing models. Similar protein aggregation in neurodegenerative diseases also triggers inflammation and NF-κB activation. However, the precise...
5.
Jin W, Zhou A, Chen J, Cen Y
Eur Rev Med Pharmacol Sci
. 2020 Jul;
24(12):6858-6863.
PMID: 32633378
Objective: This study aims at investigating the functional role of CDCA2 (cell division cycle associated 2) in enhancing proliferative and migratory abilities in melanoma by upregulating CCAD1, thus aggravating the...
6.
Sun W, Lu Y, Cai X, Li Z, Lv J, Xiang Y, et al.
Eur Rev Med Pharmacol Sci
. 2020 Jul;
24(12):6848-6857.
PMID: 32633377
Objective: This study aims to investigate the biological function of circular RNA ABCB10 (circ-ABCB10) in regulating the progression of glioma and to study the possible underlying mechanisms. Patients And Methods:...
7.
Chen J, Lei P, Zhou M
Clin Transl Oncol
. 2020 May;
22(12):2293-2302.
PMID: 32472455
Purpose: The prognosis of AML patients with chemotherapy is poor, especially those who are insensitive to and resistant to chemotherapy drugs. To clarify the underlying pathogenesis of AML and provide...
8.
Luo Z, Peng Y, Liu F, Ma J, Hu G, Lai S, et al.
Eur Rev Med Pharmacol Sci
. 2020 May;
24(9):4697-4709.
PMID: 32432733
Objective: Studies have demonstrated that long non-coding RNAs (lncRNAs) are important in the development and prognosis of prostate cancer. The aim of this study was to investigate the functions and...
9.
Wei J, Wu C, Chen J, Shang F, Guo S, Zhang X, et al.
Eur Rev Med Pharmacol Sci
. 2020 Feb;
24(2):851-861.
PMID: 32016991
Objective: Sepsis is a systemic inflammatory response that can lead to the dysfunction of many organs, including the cardiac one. Long noncoding RNAs (lncRNAs) have been shown to be involved...
10.
Zhang H, Li C, Wang X, Luo Y, Cao X, Chen J
Eur Rev Med Pharmacol Sci
. 2019 Oct;
23(18):7884-7891.
PMID: 31599450
Objective: MiR-199 expression is associated with liver cancer. Bioinformatics analysis revealed that miR-199 has a complementary binding site to the 3'-UTR region of Snail mRNA. This study investigated whether miR-199...